MUNICH-Rodenstock Group, a global innovation leader in vision care and manufacturer of biometric lenses, has announced its results for the financial year 2023. Driven by continued strong sales growth of its B.I.G. Vision product portfolio of biometric progressive lenses and the launch of MyCon lenses for children, the group increased consolidated pro-forma net sales to €506.1 million, a slight revenue increase of 0.2 percent. Previous year net sales were €505.3 million on a like-for-like basis. Rodenstock also reported 8 percent sales growth of the B.I.G. Vision product portfolio of biometric progressive lenses during 2023.